We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Brixmor Property Group
BRX
$9.67B
| $425K | 0.01% |
+18,367
| New | +$448K |
|
|
CTRA
677
DELISTED
Coterra Energy
CTRA
| $425K | 0.01% |
+13,460
| New | +$449K |
|
678
International Bancshares
IBOC
$4.76B
| $425K | 0.01% |
15,822
-4,872
| -24% | -$129K |
|
679
Regeneron Pharmaceuticals
REGN
$78.5B
| $424K | 0.01% |
832
-7,594
| -90% | -$3.71M |
|
680
Old Republic International
ORI
$10.5B
| $422K | 0.01% |
27,002
-17,294
| -39% | -$267K |
|
|
JNS
681
DELISTED
Janus Capital Group Inc
JNS
| $422K | 0.01% |
+24,671
| New | +$441K |
|
682
KB Home
KBH
$3.37B
| $421K | 0.01% |
+25,361
| New | +$387K |
|
|
SPWR
683
DELISTED
SunPower Corporation Common Stock
SPWR
| $421K | 0.01% |
+22,604
| New | +$475K |
|
684
Meritage Homes
MTH
$4.58B
| $417K | 0.01% |
+17,692
| New | +$400K |
|
685
Alkermes
ALKS
$8.22B
| $415K | 0.01% |
6,454
-21,880
| -77% | -$1.34M |
|
686
IBM
IBM
$211B
| $415K | 0.01% |
+2,671
| New | +$429K |
|
|
SHLD
687
DELISTED
Sears Holding Corporation
SHLD
| $414K | 0.01% |
+15,501
| New | +$598K |
|
688
Saic
SAIC
$4.95B
| $412K | 0.01% |
7,800
+3,000
| +63% | +$157K |
|
|
UMPQ
689
DELISTED
Umpqua Holdings Corp
UMPQ
| $412K | 0.01% |
+22,904
| New | +$404K |
|
690
Advance Auto Parts
AAP
$3.35B
| $411K | 0.01% |
+2,579
| New | +$394K |
|
|
DISCK
691
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $411K | 0.01% |
13,210
-18,420
| -58% | -$570K |
|
692
Allstate
ALL
$68B
| $407K | 0.01% |
+6,280
| New | +$431K |
|
693
Fortinet
FTNT
$119B
| $407K | 0.01% |
+49,250
| New | +$382K |
|
694
Liberty Global Class A
LBTYA
$3.62B
| $406K | 0.01% |
+9,094
| New | +$404K |
|
|
REMY
695
DELISTED
REMY INTL INC NEW COMMON
REMY
| $405K | 0.01% |
+18,300
| New | +$408K |
|
|
CAVM
696
DELISTED
Cavium, Inc.
CAVM
| $405K | 0.01% |
+5,886
| New | +$413K |
|
697
Lennox International
LII
$14.4B
| $404K | 0.01% |
3,749
-181,075
| -98% | -$20.1M |
|
698
Teradata
TDC
$2.92B
| $403K | 0.01% |
10,893
+6,293
| +137% | +$259K |
|
699
Fossil Group
FOSL
$293M
| $402K | 0.01% |
5,795
+3,345
| +137% | +$260K |
|
700
Eli Lilly
LLY
$1.02T
| $401K | 0.01% |
4,800
-39,974
| -89% | -$3.05M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.